M. Nivens's Profile

Role	Title	Level	Year	L/R
🐜	Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. 67 auth. M. Shankar-Hari, C. Vale, P. Godolphin, D. Fisher, J. Higgins, F. Spiga, J. Savović, J. Tierney, G. Baron, J. Benbenishty, L. Berry, N.Jaffer Broman, A. Cavalcanti, R. Colman, Stefanie De Buyser, ... L. Derde, P. Domingo, S. Omar, A. Fernández‐Cruz, T. Feuth, Felipe García, R. García-Vicuña, I. González-Álvaro, A. Gordon, R. Haynes, O. Hermine, P. Horby, N. Horick, Kuldeep Kumar, B. Lambrecht, M. Landray, L. Leal, D. Lederer, E. Lorenzi, X. Mariette, N. Merchante, N. Misnan, Shalini V. Mohan, M. Nivens, J. Oksi, J. Pérez-Molina, R. Pizov, R. Porcher, S. Postma, Reena Rajasuriar, A. Ramanan, P. Ravaud, P. Reid, A. Rutgers, A. Sancho-López, T. Seto, S. Sivapalasingam, A. Soin, N. Staplin, J. Stone, G. Strohbehn, J. Sundén-Cullberg, J. Torre-Cisneros, L. Tsai, H. van Hoogstraten, T. van Meerten, V. Veiga, P. Westerweel, S. Murthy, Janet Diaz, J. Marshall, J. Sterne	9	2021	9 🐜
🐜	Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. 16 auth. M. Wechsler, M. K. Ruddy, I. Pavord, E. Israel, K. Rabe, L. Ford, J. Maspero, R. Abdulai, Chih-Chi Hu, R. Martincova, ... A. Jessel, M. Nivens, N. Amin, D. Weinreich, G. Yancopoulos, H. Goulaouic	7	2021	7 🐜
🐜	The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. 10 auth. A. Marcus, Jun Zhou, A. O'brate, E. Hamel, J. Wong, M. Nivens, ... A. El-Naggar, T. Yao, F. Khuri, P. Giannakakou	6	2005	6 🐜
🐜	Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. 16 auth. K. Rabe, B. Celli, M. Wechsler, R. Abdulai, Xiao-peng Luo, M. Boomsma, H. Staudinger, J. Horowitz, A. Baras, M. Ferreira, ... M. K. Ruddy, M. Nivens, N. Amin, D. Weinreich, G. Yancopoulos, H. Goulaouic	6	2021	6 🐜
🐜	Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. 9 auth. I. Hall, A. Fowler, Abhya Gupta, K. Tetzlaff, M. Nivens, M. Sarno, ... H. Finnigan, E. Bateman, E. Rand Sutherland	6	2015	6 🐜
🐜	Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. 13 auth. P. Woodruff, Michael Wolff, J. Hohlfeld, N. Krug, M. Dransfield, E. Rand Sutherland, Gerard J Criner, V. Kim, A. Prasse, M. Nivens, ... K. Tetzlaff, R. Heilker, J V Fahy	6	2010	6 🐜
🦁	Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase M. Nivens, T. Felder, A. Galloway, M. Peña, Jeffery J. Pouliot, H. Spencer	5	2004	5 🦁
🐬	The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2–4 COPD: results from two 6-week crossover studies G. Feldman, J. Bernstein, A. Hamilton, M. Nivens, L. Korducki, C. Laforce	5	2014	5 🐬
🐜	Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical Parameters 15 auth. Christine R. Xu, A. Rafique, Terra Potocky, A. Paccaly, Patrick Nolain, Q. Lu, M. Iglesias-Rodriguez, G. St John, M. Nivens, Vanaja Kanamaluru, ... J. Fairhurst, T. Ishii, R. Maldonado, E. Choy, P. Emery	5	2020	5 🐜
🐜	Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. 17 auth. R. Spiera, S. Unizony, Kenneth J. Warrington, Jennifer Sloane, A. Giannelou, M. Nivens, B. Akinlade, Wanling Wong, R. Bhore, Yong Lin, ... Frank Buttgereit, Valérie Devauchelle-Pensec, A. Rubbert-Roth, G. Yancopoulos, Frederic Marrache, Naimish Patel, Bhaskar Dasgupta	5	2023	5 🐜